PE20081343A1 - SOLID PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF IBANDRONIC ACID OR A SALT OR A PHARMACEUTICALLY ACCEPTABLE HYDRATE OF THE SAME, PROCEDURE FOR THE PREPARATION OF SAID COMPOSITION BY DIRECT COMPRESSION, PHARMACEUTICAL FORMULATIONS THAT - Google Patents
SOLID PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF IBANDRONIC ACID OR A SALT OR A PHARMACEUTICALLY ACCEPTABLE HYDRATE OF THE SAME, PROCEDURE FOR THE PREPARATION OF SAID COMPOSITION BY DIRECT COMPRESSION, PHARMACEUTICAL FORMULATIONS THATInfo
- Publication number
- PE20081343A1 PE20081343A1 PE2007001522A PE2007001522A PE20081343A1 PE 20081343 A1 PE20081343 A1 PE 20081343A1 PE 2007001522 A PE2007001522 A PE 2007001522A PE 2007001522 A PE2007001522 A PE 2007001522A PE 20081343 A1 PE20081343 A1 PE 20081343A1
- Authority
- PE
- Peru
- Prior art keywords
- composition
- salt
- same
- procedure
- preparation
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- MPBVHIBUJCELCL-UHFFFAOYSA-N Ibandronate Chemical compound CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O MPBVHIBUJCELCL-UHFFFAOYSA-N 0.000 title abstract 2
- 229960005236 ibandronic acid Drugs 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 239000007787 solid Substances 0.000 title abstract 2
- 238000007907 direct compression Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000001913 cellulose Substances 0.000 abstract 2
- 239000000314 lubricant Substances 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 1
- 235000010980 cellulose Nutrition 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000007884 disintegrant Substances 0.000 abstract 1
- MVPICKVDHDWCJQ-UHFFFAOYSA-N ethyl 3-pyrrolidin-1-ylpropanoate Chemical compound CCOC(=O)CCN1CCCC1 MVPICKVDHDWCJQ-UHFFFAOYSA-N 0.000 abstract 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 1
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 1
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 1
- 235000019814 powdered cellulose Nutrition 0.000 abstract 1
- 229920003124 powdered cellulose Polymers 0.000 abstract 1
- 229940045902 sodium stearyl fumarate Drugs 0.000 abstract 1
- 239000000454 talc Substances 0.000 abstract 1
- 229910052623 talc Inorganic materials 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
REFERIDA A UNA COMPOSICION FARMACEUTICA SOLIDA ORAL EN FORMA DE DOSIFICACION UNITARIA QUE COMPRENDE ACIDO IBANDRONICO O UNA SAL DEL MISMO EN UNA CANTIDAD DE 30% A 37% EN PESO DE LA DOSIFICACION, UN DILUYENTE EN UNA CANTIDAD DE 55% A 65%, UN AGENTE DESINTEGRANTE EN UNA CANTIDAD DE 0,5% A 1,5%, UN LUBRICANTE EN UNA CANTIDAD DE 4,5% A 5,5%. EL DILUYENTE PUEDE SER CELULOSA MICROCRISTALINA, CELULOSA EN POLVO, CELULOSA MICROFINA, ENTRE OTROS; EL LUBRICANTE PUEDE SER ESTEARIL FUMARATO DE SODIO, TALCO, ACEITE, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UN PROCESO DE PREPARACIONREFERRED TO AN ORAL SOLID PHARMACEUTICAL COMPOSITION IN THE FORM OF A UNIT DOSAGE THAT INCLUDES IBANDRONIC ACID OR A SALT OF THE SAME IN AN AMOUNT OF 30% TO 37% BY WEIGHT OF THE DOSAGE, A THINNER IN AN AMOUNT OF 55% TO 65%, AN AGENT DISINTEGRANT IN AN AMOUNT OF 0.5% TO 1.5%, A LUBRICANT IN AN AMOUNT OF 4.5% TO 5.5%. THE THINNER MAY BE MICROCRYSTALLINE CELLULOSE, POWDERED CELLULOSE, MICROFINE CELLULOSE, AMONG OTHERS; THE LUBRICANT MAY BE SODIUM STEARYL FUMARATE, TALC, OIL, AMONG OTHERS. IT IS ALSO REFERRED TO A PREPARATION PROCESS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP060104910 AR058512A1 (en) | 2006-11-09 | 2006-11-09 | SOLID PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF IBANDRONIC ACID OR A SALT OR A PHARMACEUTICALLY ACCEPTABLE HYDRATION OF THE SAME, PREPARATION PROCEDURE FOR THIS COMPOSITION BY DIRECT COMPRESSION, PHARMACEUTICAL FORMULATIONS THAT PREPARE AND PROCEDURE TO PREPARE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20081343A1 true PE20081343A1 (en) | 2008-09-24 |
Family
ID=39059286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007001522A PE20081343A1 (en) | 2006-11-09 | 2007-11-06 | SOLID PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF IBANDRONIC ACID OR A SALT OR A PHARMACEUTICALLY ACCEPTABLE HYDRATE OF THE SAME, PROCEDURE FOR THE PREPARATION OF SAID COMPOSITION BY DIRECT COMPRESSION, PHARMACEUTICAL FORMULATIONS THAT |
Country Status (9)
| Country | Link |
|---|---|
| AR (1) | AR058512A1 (en) |
| BR (1) | BRPI0704025A (en) |
| CL (1) | CL2007003210A1 (en) |
| CO (1) | CO5930065A1 (en) |
| DO (1) | DOP2007000134A (en) |
| EC (1) | ECSP077881A (en) |
| MX (1) | MX2007014056A (en) |
| PE (1) | PE20081343A1 (en) |
| UY (1) | UY30697A1 (en) |
-
2006
- 2006-11-09 AR ARP060104910 patent/AR058512A1/en unknown
-
2007
- 2007-11-06 EC ECSP077881 patent/ECSP077881A/en unknown
- 2007-11-06 PE PE2007001522A patent/PE20081343A1/en not_active Application Discontinuation
- 2007-11-07 UY UY30697A patent/UY30697A1/en not_active Application Discontinuation
- 2007-11-07 CL CL2007003210A patent/CL2007003210A1/en unknown
- 2007-11-08 CO CO07118248A patent/CO5930065A1/en not_active Application Discontinuation
- 2007-11-09 BR BRPI0704025 patent/BRPI0704025A/en not_active Application Discontinuation
- 2007-11-09 DO DO2007000134A patent/DOP2007000134A/en unknown
- 2007-11-09 MX MX2007014056A patent/MX2007014056A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0704025A (en) | 2008-07-01 |
| DOP2007000134A (en) | 2008-06-15 |
| AR058512A1 (en) | 2008-02-06 |
| CL2007003210A1 (en) | 2008-03-14 |
| MX2007014056A (en) | 2009-02-19 |
| ECSP077881A (en) | 2008-06-30 |
| CO5930065A1 (en) | 2008-06-27 |
| UY30697A1 (en) | 2008-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9901568B2 (en) | Pharmaceutical compositions of 5-hydroxytryptophan and serotonin-enhancing compound | |
| AR075735A1 (en) | PHARMACEUTICAL COMPOSITIONS OF IMMEDIATE RELEASE THAT INCLUDE OXYCODONE AND NALOXONE. USE | |
| RU2016122609A (en) | COMPOSITIONS OF AZAINDOL COMPOUNDS | |
| FI2498756T4 (en) | Tablet formulations of neratinib maleate | |
| RU2012142811A (en) | PHARMACEUTICAL COMPOSITIONS AND ORAL ORAL DOSED FORMS OF LEVERODOPE'S MEDICINAL PRODUCTS AND METHODS OF APPLICATION | |
| MX2015017307A (en) | USE OF PRIDOPIDINE IN HIGH DOSE FOR THE TREATMENT OF HUNTINGTON'S DISEASE. | |
| PE20040121A1 (en) | CONTROLLED RELEASE PHARMACEUTICAL FORMULATIONS OF 5,8,14-TRIAZATETRACICLO [10.3.1.02,11.04.9] -HEXADECA-2- (11), 3,5,7,9-PENTAENE | |
| SI3079671T1 (en) | Orally disintegrating solid dosage unit containing an estetrol component | |
| CO5390076A1 (en) | PHARMACEUTICAL COMPOSITIONS | |
| PE20140389A1 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MYELOFIBROSIS | |
| CA2601955A1 (en) | Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer | |
| BRPI0922796A2 (en) | PHARMACEUTICAL TABLET FOR ORAL ADMINISTRATION AND MANUFACTURING METHOD | |
| CO5060477A1 (en) | DOSAGE FORM OF NEFAZODONA | |
| AR077546A1 (en) | FORMULATIONS OF TABLETS OF 3-CYANOQUINOLINE AND USES OF THE SAME | |
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| PE20081799A1 (en) | IMPROVEMENTS IN OR RELATED TO THE MEDICINAL COMPOSITIONS | |
| JP2018501217A5 (en) | ||
| AR061166A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR SUSTAINED RELEASE OF PHENYLPHERINE | |
| AR061790A1 (en) | SOLID PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION, FORMULATIONS OF IMMEDIATE RELEASE TABLETS OF A THROMBIN RECEIVER ANTAGONIST, AND ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT | |
| BR122021012549B8 (en) | ORAL MELATONIN DISSOLUTION COMPOSITION WITH ACIDIFYING AGENT THAT MAKES MELATONIN SOLUBLE IN SALIVA | |
| RU2006104009A (en) | PHARMACEUTICAL DRUG FORM | |
| JP2009507048A5 (en) | ||
| MX2023001014A (en) | Pharmaceutical compositions comprising venglustat. | |
| JP2009242366A (en) | Prolonged antipyretic analgesic anti-inflammatory agent | |
| EA201170583A1 (en) | NEW COMPOSITION FOR THE TREATMENT OF ESSENTIAL THROMBOCYTEMIA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |